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1.1 Introduction
In today’s increasingly globalized world – characterized by the extensive 
movement of people, goods and services, capital and ideas across national 
borders (Kruk, 2012) – a wide range of transborder health threats, 
such as emerging and re-emerging infectious diseases, rising rates of 
noncommunicable diseases (NCDs) and spreading antimicrobial resistance 
(AMR), emphasize the need for collective action to promote and protect 
population health (Lee, Pang and Tan, 2013; WHO, 2002). New forms of 
collaboration are particularly important given that the social, economic, 
political and commercial determinants of health reside outside of the health 
sector. Within this transnational and cross-cutting arena, the efforts of 
governments or other relevant actors to steer collective action to address 
health and its determinants through whole-of-government and whole-of-
society approaches constitute “governance for health” (Kickbusch and 
Gleicher, 2012). In this context, governance is diffused from a State-centred 
model to a collaborative one, and is influenced by a wide array of State and 
non-State actors, at times with competing interests and different approaches 
(Kickbusch and Gleicher, 2012). Spanning across multiple sectors, from 
governmental to private for-profit organizations, these actors may operate 
at the global, regional, national or subnational level (Szlezák et al., 2010).
Governance for health at the regional level has the potential to enhance 
coherence across national health policies, to shape and coordinate broad 
multicountry health initiatives, and to align domestic needs with global 
commitments (Kickbusch and Szabo, 2014; Riggirozzi and Yeates, 2015; 
Yeates and Riggirozzi, 2015). In this regard, effective governance can 
harmonize the agendas of various stakeholders and coordinate their 
actions. These actors can also participate in global governance for health 
by, for instance, contributing to agenda-setting and shaping global 
norms (Kickbusch and Szabo, 2014). The process of regionalizing health 
cooperation – which we define as the establishment of formal or informal 
arrangements for public health cooperation at the regional level (Liverani, 
Hanvoravongchai and Coker, 2012; Riggirozzi and Yeates, 2015) – was 
influenced by the World Health Organization (WHO), which has operated 
through a decentralized system of six regional offices since its establishment 
in 1948.
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Being home to more than half of the world’s population, Asia presents a 
breadth of economic, political, social, cultural and geographical diversity 
both across and within countries, associated with different health and 
development challenges (Lee, Pang and Tan, 2013). Nonetheless, important 
public health concerns are shared across Asian countries, particularly 
in subregional contexts (Lamy and Phua, 2012a & 2012b; Liverani, 
Hanvoravongchai and Coker, 2012 & 2013; Nodzenski et al., 2016; Pang, 
2016; Thomas, 2006). For example, geographical areas in East and South-East 
Asia have been particularly vulnerable to transnational health threats, such 
as severe acute respiratory syndrome (SARS), dengue and highly pathogenic 
avian influenza H5N1. This shared vulnerability has encouraged the 
development of regional surveillance and response programmes (Liverani, 
Hanvoravongchai and Coker, 2012). Furthermore, regional programmes for 
political and economic cooperation have provided the institutional bases 
from which public health programmes can be developed and implemented 
(Liverani, Hanvoravongchai and Coker, 2012). Examples of such institutional 
venues include the Association of Southeast Asian Nations (ASEAN) and the 
South Asian Association for Regional Cooperation (SAARC).
This chapter gives an overview of these developments in regional 
governance for health in Asia, with specific examples and case studies 
from different contexts and health sectors. The chapter begins with 
a broad introduction to the regional health architecture – which we 
define as the group of actors with a primary intent to improve health by 
addressing common threats in the region, and the governance, financing 
and delivery arrangements in which these actors operate (Hoffman, Cole 
and Pearcey, 2015) – describing the key groups of actors and examples of 
existing frameworks for regional health cooperation. In the first part of the 
chapter, the case of ASEAN is discussed in-depth to illustrate institutional 
challenges to, and opportunities for, regional cooperation in Asia. The case 
of communicable disease governance in Asia is then presented to shed light 
on the wider governance dynamics in the region using infectious diseases 
as one of the policy tracers. Key achievements of, opportunities for and 
challenges to governance for health in Asia are discussed, following which 
we comment on the potential for the region to engage in and contribute 
more broadly to global governance for health.
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1.2 The need for collective action to manage 
transboundary health problems
Despite marked improvements in health indicators, many Asian 
countries face significant challenges, particularly in the context of rapid 
demographic and epidemiological transitions and the associated “double 
burden” of communicable diseases and NCDs, and an ageing population 
(Chongsuvivatwong et al., 2011; Narain and Bhatia, 2010; Nodzenski et al., 
2016). Emerging and re-emerging infectious diseases are a key concern due 
to population movements, both intra- and cross-boundary, high-density 
urbanization and climate change, as are persisting inequalities in health 
outcomes (Chongsuvivatwong et al., 2011). Furthermore, the process of 
trade liberalization has seen the spread and growth of Asia’s tobacco, 
alcohol and ultra-processed food manufacturers, associated with an 
increase in risks to health throughout the region (Baker, Kay and Walls, 
2015). For example, China has witnessed a rapid increase in per capita 
alcohol consumption, from approximately 3 litres of pure alcohol in 2004 
to just under 5 litres in 2009, alongside a steady rise in the production of 
alcoholic beverages (Tang et al., 2013). Asia is also vulnerable to natural 
and anthropogenic disasters, particularly in the South-East region, such 
as earthquakes, typhoons, floods, as well as other problems that affect 
health such as environmental pollution (Chongsuvivatwong et al., 2011). 
In recognition of the transnational nature of these threats, mechanisms 
to promote regional health cooperation and coordination have been 
established. While regional governance mechanisms already existed for 
other areas of public policy in Asia, health emerged as a new item on the 
agendas of national authorities and international organizations, particularly 
following the SARS and H5N1 outbreaks in 2003 and 2004, respectively, 
which demonstrated that health threats can have severe impacts on 
economic growth and stability (Nodzenski et al., 2016). For example, the 
World Bank estimates that the 2003 SARS outbreak cost the global economy 
US$ 54 billion (Jonas, 2013).
1.3 The regional health architecture 
As discussed in the introduction, the regional health architecture consists 
of the actors who seek to address common health threats and their 
determinants in Asia, and the arrangements that shape their interactions 
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(Hoffman, Cole and Pearcey, 2015). In particular, central to the regional 
architecture are national governments (including ministries of health and 
other bodies such as ministries of finance), regional and non-regional 
donors, international organizations such as the WHO, civil society 
organizations (CSOs), private foundations, global health partnerships 
and for-profit private sector actors. There is, however, a lack of consensus 
among stakeholders as to how collective action to address transnational 
health problems should be supported and steered; indeed, regional health 
cooperation has been relatively limited in Asia as compared to, for example, 
the Americas with the Pan American Health Organization (PAHO) or 
Europe with the European Commission (Lee, 2013). In the following 
sections, we provide an overview of these different actors and their roles in 
regional governance for health.
1.3.1 WHO regional offices
WHO is central to the health architecture in Asia and its efforts are 
spearheaded by the Regional Office for South-East Asia, the Regional 
Office for the Western Pacific and the Regional Office for the Eastern 
Mediterranean. The regional offices are broadly composed of WHO 
Member States representing one geographical or cultural area; however, the 
particular composition of each region has changed over time as a result of 
historical political divisions between Member States (Fee, Cueto and Brown, 
2016). For example, due to the enduring conflict between Pakistan and 
India, Pakistan joined the Regional Office for the Eastern Mediterranean 
despite its geographical proximity to the Regional Office for South-East 
Asia (Fee, Cueto and Brown, 2016). While carrying out much of WHO’s 
programmatic work and ensuring coordination and coherence with the 
Organization’s global policy objectives, the regional offices also maintain a 
certain autonomy, working according to their own health agendas through 
the resolutions and decisions of their respective regional committees 
(Youde, 2012). Although improved recently, cooperation between WHO 
regional offices had been a challenge in Asia due to the historical split of 
regional clusters into separate WHO regional offices soon after the Second 
World War. The division of offices and bureaucratic rigidity hindered 
regional collaboration and have contributed in part to fragmentation 
across health programmes (Chongsuvivatwong et al., 2011; Liverani, 
Governing complexity: The regional health architecture in Asia
23
Hanvoravongchai and Coker, 2012). Despite these challenges, the WHO 
regional offices play an important role in providing normative guidance 
and technical support to Member countries, as well as facilitating the 
formulation of policy and regulatory mechanisms in the region.
WHO also established the Asia Pacific Observatory on Health Systems 
and Policies (the APO) in 2011, a multisector partnership that is active 
in the region in terms of country-level policy development, health 
systems research and evidence generation, as well as strengthening of 
health systems capacity (APO, 2018). There are signs of growing regional 
cooperation around particular disease threats, such as pandemic influenza, 
focused on surveillance, monitoring and reporting (Lee, 2013). Indeed, the 
effective implementation of WHO’s International Health Regulations (IHR) 
(2005), which require governments to build and strengthen their capacities 
to prevent, report and respond to public health risks of international 
concern, could also facilitate improved integration and coordination at the 
regional level in Asia (WHO, 2005).
1.3.2 ASEAN as an example of a regional health forum
Beyond national governments and WHO and its regional offices, the health 
architecture in Asia has seen a proliferation of actors from the health 
sector and beyond. In particular, health cooperation has featured on the 
agendas of several regional organizations in Asia, albeit to varying extents, 
including, for instance, the Asian Development Bank (ADB), the Asia Pacific 
Economic Cooperation (APEC) forum, SAARC, the Shanghai Cooperation 
Organization and ASEAN (Caballero-Anthony and Amul, 2014).
In South-East Asia, for example, ASEAN has emerged as a key institutional 
actor in the regional health architecture, with particular influence in 
convening national governments for negotiation and consensus-building 
for health (Nodzenski et al., 2016). Established in 1967 as a coalition of 
five countries in South-East Asia – Indonesia, Malaysia, Philippines, 
Singapore and Thailand – ASEAN aims to promote regional peace and 
stability, as well as political, economic and social cooperation among its 
members (ASEAN, n.d.-a). Since its establishment, the organization has 
progressively grown to include ten countries from South-East Asia, and 
has engaged deeply with neighbouring countries such as China, Japan and 
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the Republic of Korea in what is known as the ASEAN Plus Three process. 
While health was not a priority of ASEAN in the early history of this 
organization, after the SARS outbreak in 2003, public health has featured 
more prominently on ASEAN’s agenda (Liverani, Hanvoravongchai 
and Coker, 2013). The 2007 ASEAN Charter was particularly influential 
in generating political momentum for public health as it established the 
Socio-Cultural Community (ASCC) pillar, which supports ASEAN’s 
health-related programming (Nodzenski et al., 2016). However,regional 
health cooperation has largely focused on infectious diseases, whereas 
NCDs and health systems strengthening, for instance, have historically 
received less attention and fewer resources (Caballero-Anthony and Amul, 
2014; Lamy and Phua, 2012).
Despite much promise for improved regional governance for health, 
previous ASEAN frameworks for health cooperation, such as the Strategic 
Framework on Health and Development (2010–2015), saw very few 
programmes being implemented on the ground (Lamy and Phua, 2012). 
Low-level institutionalization and a lack of funding (often with reliance 
on donor funding) and technical expertise are key barriers to effective 
collaboration across member states (Nodzenski et al., 2016). Indeed, 
without the necessary funding, other priority areas in the region, such as 
minimizing political conflict and maintaining regional stability (Lee, Pang 
and Tan, 2013), have tended to be prioritized (Liverani, Hanvoravongchai 
and Coker, 2012). Structural factors such as political diversity, economic 
inequalities and differences in operational capacity between ASEAN 
member countries are also barriers to effective health cooperation 
(Nodzenski et al., 2016). Finally, the principle of non-interference applied 
by the “Political and Security pillar”, which is based on the primacy of State 
sovereignty, informs negotiations between member countries, recognition 
of which has led to the concept of the “ASEAN way”, which involves a slow 
and complex decision-making process that operates by consensus (Liverani, 
Hanvoravongchai and Coker, 2013). Although these norms and practices 
can work to build trust among its members, when coupled with a lack of 
political integration and insufficient funding, they are thought to challenge 
cooperation and the design of regional health governance frameworks 
(Nodzenski et al., 2016).
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Despite these challenges, ASEAN’s re-organized Post-2015 Health 
Development Agenda – which was led by Thailand through a two-year 
negotiation aimed at improving performance of health collaboration and 
linking with global commitments to the 2030 Agenda for Sustainable 
Development – places ASEAN in a good position to take on a greater health 
leadership role in the region and globally. The new agenda also seeks to 
position its member countries in the broader global health space and to 
strengthen collaboration with non-regional countries and development 
partners (ASEAN, 2016). Moving away from a fragmented approach of 
more than 100 programmes and projects, the new regional health agenda 
is organized into four health clusters that provide strategic leadership to 
develop, implement, monitor and evaluate regional programmes with 
the aim of improved performance and effectiveness within their thematic 
focus areas: promoting healthy lifestyles, responding to all hazards and 
emerging threats, strengthening health systems and access to care, and 
ensuring food safety (ASEAN, 2016). Each regional project is coordinated 
by a lead country and co-led by another country with technical input 
solicited from other regional and global actors (ASEAN, n.d.-b). While 
non-legally binding, this new integrated governance framework may 
help improve health coordination and performance across member states 
horizontally by outlining joint health priorities and providing strategic 
leadership (ASEAN, n.d.-b). Progress is regularly reported to senior officials 
during the biannual meeting of Health Ministers. Of particular importance 
is the organization’s recognition that health should be incorporated into 
all policies (ASEAN, 2016), which could encourage more policy coherence 
within the Socio-Cultural pillar as well as the other two pillars of the 
ASEAN community (Political-Security and Economic), and across initiatives 
in the region. At the same time, the new agenda may strengthen ASEAN’s 
position as an intermediary between global normative frameworks such 
as the Sustainable Development Goals (SDGs) and national policy-making 
and implementation.
1.3.3 International partners
In addition to State cooperation in regional organizations such as ASEAN 
and the core roles of national governments and WHO throughout Asia, 
bilateral donors from outside of the region, such as the United States of 
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America (USA), Australia and the European Union (EU), have also engaged 
in regional cooperation. Multilateral institutions are another group of key 
players in the regional health architecture, such as the ADB, the Islamic 
Development Bank, the World Bank and the World Trade Organization 
(WTO). For example, the ADB has outlined health infrastructure, health 
governance and financing as key priority areas in their Operation Plan for 
Health 2015–2020, which they will support by investing in information 
and communications technology (ICT) and public–private partnerships 
(ADB, 2015).
Despite the participation of Asian stakeholders in some of these global 
institutions such as the WTO, researchers have argued that the region 
has not yet achieved the impact that it could (Fidler, 2010; Gostin, 2013; 
Yeling, Lee and Pang, 2012). For instance, Gostin (2013) argues that Asia 
could be “a global leader in fighting unfair trade rules that disadvantage 
the region and other resource-poor regions of the world”, while Asian 
institutions could capitalize on political and economic power in the region 
to promote more equitable international trade policy and arrangements, 
including South–South partnerships. For example, many Asian countries 
have pharmaceutical manufacturing capacity – such as China, India, 
Indonesia, Japan, Pakistan and Thailand – which uniquely positions the 
region (outside of Europe and the USA) in negotiations surrounding 
issues of access to medicines and intellectual property rights (Gostin, 2013; 
Moon and Szlezák, 2013; Smith, Correa and Oh 2009). Indeed, India has 
emerged as a world leader in this regard as a low-priced supplier of generic 
medicines. The value of pharmaceutical exports from India was US$ 17.27 
billion in 2017–2018 and it is the largest supplier of generic medicines 
globally, contributing up to 20–22% of global export volume (IBEF, 2018). 
In particular, India manufactures generic antiretroviral medicines, which 
facilitated the rapid scale up of treatment for human immunodeficiency 
virus (HIV) in low-resource settings, particularly in Africa (Waning, 
Diedrichsen and Moon, 2010). Given their leadership around intellectual 
property rights and access to essential medicines, coupled with their 
strategic position as a BRICS (Brazil, Russia, India, China and South Africa) 
country, India is well placed to assume a broader leadership role for South–
South health collaborations that facilitate access to medicines and medical 
products.
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A number of foundations and global health initiatives, such as the Bill and 
Melinda Gates Foundation and the Global Fund to Fight AIDS, Tuberculosis 
and Malaria (the Global Fund), have also played important roles in 
financing health programmes and, in some instances, health cooperation 
in the region. For example, for the period 2017–2020, the Global Fund 
allocated over US$ 2 billion to countries in Asia, in partnership with the 
ADB, to support the financing, design and implementation of HIV, malaria 
and TB programmes, as well as health systems strengthening activities, 
mostly through intercountry cross-border programmes and collaboration 
(The Global Fund, 2017a). In addition, Bloomberg Philanthropies has been 
active in the area of tobacco control in Asian low- and middle-income 
countries (LMICs) (Mackay, Ritthiphakdee and Reddy, 2013), particularly 
through the Bloomberg Initiative to Reduce Tobacco Use Grants Program 
(Tobacco Control Grants, n.d.). However, while international funding for 
health and social development has been important in Asia, within ASEAN, 
most member states currently rely on domestic funding to support such 
programmes, with few exceptions, including Cambodia and Lao People’s 
Democratic Republic. Furthermore, all middle-income countries within 
ASEAN have transitioned or are in the transitioning process from funding 
support of the Global Fund and Gavi, the Vaccine Alliance.
Key challenges have also emerged in the context of international partners’ 
support for health and development programmes. Ensuring accountability 
and effective coordination of donors and donor-sponsored programmes 
has been a long-standing issue in Asia, as well as in other LMIC settings, at 
times leading to inefficient duplication of health programmes and gaps in 
the delivery of essential services. In Cambodia, for instance, fragmentation 
of donor-sponsored health programmes has been a challenge for many 
years, although new mechanisms have been developed recently to promote 
local ownership and to improve coordination between the government and 
international development partners (Box 1.1). The Philippines has faced 
similar challenges in coordinating various actors and programmes, and also 
offers important lessons in terms of establishing institutional arrangements, 
such as the Sector Development Approach for Health (SDAH) (World 
Bank, 2011), to ensure alignment of priorities and to harmonize activities to 
enhance donor and lender accountability (Box 1.2).
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Box 1.1 International organizations and health sector governance in 
Cambodia
Following decades of turmoil and conflicts, from the early 1990s, Cambodia 
has engaged in a process of democratic transition and institutional reforms, 
which opened the country to the involvement of the full spectrum of 
international development actors, including regional donors such as the 
Japan International Cooperation Agency (JICA) and the Korea International 
Cooperation Agency (KOICA) and non-regional donors such as the United 
States Agency for International Development (USAID), Department of 
Foreign Affairs and Trade (DFAT) Australia, Department for International 
Development (DfID) in the United Kingdom (UK), and the Deutsche 
Gesellschaft für Internationale Zusammenarbeit (GIZ). In the health sector, 
sustained efforts have been made to improve service delivery and address 
health challenges and inequities, with substantive financial and technical 
support from international partners; it was estimated that the official 
development assistance (ODA) for health to Cambodia increased by 628% in 
the period 2000–2010 (WHO, 2010). These efforts, combined with domestic 
economic growth, have contributed to a general improvement in population 
health, especially in the areas of infectious diseases, child and maternal 
health. However, coordination of international donors, and between different 
donor-sponsored initiatives, has been a major challenge in Cambodia, at 
times resulting in the duplication of programmes and a lack of synergies. 
In addition, international organizations have tended to focus on vertical 
programmes in keeping with the global health agenda, but other important 
public health priorities in the country (such as the increasing burden from 
NCDs) have been neglected (Liverani, Chheng and Parkhurst, 2018).
In the past decade, however, new policy mechanisms have been developed 
to support more efficient policy dialogue and coordination between domestic 
and international stakeholders. In particular, established in 2004, the Technical 
Working Group for Health (TWG-H) is a participatory forum for health 
policy-making to improve aid effectiveness, harmonization and alignment 
with development partners (Liverani, Chheng and Parkhurst, 2018). Second, 
the strengthening of institutional structures in the Ministry of Health (MoH) 
and economic growth have increased local capacities for decision-making and 
programme implementation. In 2007, for example, the Cambodian government 
introduced a Midwifery Incentive Scheme, which aimed to reduce maternal 
mortality rates by paying midwives US$ 15 or US$ 10 per live birth
Governing complexity: The regional health architecture in Asia
29
at public health centres and government hospitals, respectively. This scheme, 
which is entirely implemented and financed by the national government, 
illustrates a shift to local leadership in policy formulation and management. 
The Cambodian government has also taken greater financial responsibility 
for health policies that were originally introduced and supported only by 
international actors – such as the “health equity funds”, a financing mechanism 
to improve access to health services for the poor – another indicator of change, 
which may improve sustainability of interventions and local ownership (Khan 
et al., 2018).
Box 1.2 Health cooperation in the Philippines
Over the past two decades, Development Assistance for Health (DAH) in the 
Philippines has played a supportive role during the implementation period of 
the Millennium Development Goals (MDGs) and the revitalization of universal 
health coverage (UHC) under the Aquino administration. As an LMIC in 
South-East Asia, Philippines has been a recipient of external funding that 
supported ongoing domestic health reforms and investments. Major bilateral 
partners include the USA, Japan and Spain, with whom the Philippines has 
deep historical ties; newer partners include Germany and Republic of Korea. 
Multilateral donors and lenders include the ADB (with its headquarters in 
Manila), the EU, the Global Fund, the World Bank, WHO and other UN agencies.
The Philippine National Health Accounts reveal that while health spending 
from external sources increased from Philippine pesos (PhP) 7.681 billion (US$ 
144 million) in 2009 to PhP 13.976 billion (US$ 261 million) in 2016, their share 
of the total budget remained at slightly more than 2% over the ten-year period 
(National Statistical Coordinating Board, 2013; PSA, n.d.). The Department 
of Health (DoH) also estimated that DAH for the period 2014–2019 amounts 
to PhP 22.8 billion (US$ 426 million), the majority of which is in the form of 
grants. DAH-supported projects and programmes include technical assistance 
to improve the delivery of health services in maternal and child health, 
malaria, tuberculosis (TB) and HIV (DoH, 2014).
In accordance with the 2005 Paris Declaration on Aid Effectiveness, the DoH 
adopted the SDAH in 2007 (World Bank, 2011) – a variation of the sector-wide
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approach (SWAp) implemented in several countries to ensure alignment of 
priorities, harmonize activities and processes, and enhance donor and lender 
accountability. SDAH ensures that development assistance is aligned with 
the national health strategy, effectively coordinated to reduce duplication and 
fragmentation, and projects are sustained and institutionalized in appropriate 
agencies. Through its Bureau of International Health Cooperation, the DoH 
coordinates with bilateral and multilateral partners, oversees the implementation 
of DAH-supported projects, and convenes coordination mechanisms with 
partner agencies such as the annual Joint Appraisal and Planning Initiative (JAPI) 
meetings where government and development partners jointly review and report 
on progress towards the implementation of UHC.
Apart from the health-related MDGs and implementation of UHC, another 
area of international health cooperation and development assistance unique to 
the Philippines is emergency preparedness and humanitarian response. Due to 
the Philippines’ high vulnerability to natural disasters such as typhoons, storm 
surges, earthquakes and volcanic eruptions, external partners have supported 
the efforts of the DoH in building capacity for disaster preparedness and 
providing essential health services in the immediate recovery and long-term 
rehabilitation phase. During times of calamity, the cluster approach adopted 
widely in the humanitarian response community is activated across all 
sectors. With support from the WHO country office, the DoH activates the 
health cluster, which convenes organizations involved in the systemwide 
response, including bilateral and multilateral agencies, and nongovernmental 
organizations (NGOs). For example, when the Philippines was hit in 2013 by 
Typhoon Haiyan, the strongest typhoon to ever hit land in history, the country 
received substantial humanitarian aid to fund immediate recovery and 
long-term rehabilitation. The Financial Tracking Service of the UN Office for 
the Coordination of Humanitarian Affairs (UN OCHA) recorded that in 2014, 
US$ 54.1 million went to health, US$ 14.5 million to nutrition, and US$ 61.5 
million to water, sanitation and hygiene (WASH), covering 68.1%, 96.4% and 
76.0% of the projected need for each sector, respectively (UN OCHA, n.d.).
The Philippines has also been leading internationally in trade in health 
services. In response to a rising demand from high-income countries (HICs), 
health workers, particularly nurses, have become one of the Philippines’ most 
valuable exports. The emigration of health professionals has been facilitated 
by a regulated system supported by a substantial number of nursing and 
caregiver schools, recruitment agencies linked to overseas employers, and the 
use of bilateral labour agreements with destination countries that ensure the
Governing complexity: The regional health architecture in Asia
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protection of migrant workers (Institute of Health Policy and Development 
Studies, 2005). Meanwhile, the Philippines has also become a world leader 
in business process outsourcing, providing cheap labour for clients in HICs 
to deliver a wide range of remote services, including medical transcription 
services. In 2005, the size of the Philippine medical transcription business 
was estimated at US$ 150 million, although it only accounted for 1.7% of the 
industry globally (Ramo, 2005). Finally, in recent years, the Philippines has 
also pursued initiatives to promote its growing medical tourism industry. 
However, as the country continues to grapple with health care problems 
domestically, it is struggling to compete with neighbouring countries with 
more mature medical tourism industries, such as Malaysia, Singapore, and 
Thailand (Pocock and Phua, 2011).
Currently, the Philippines is also engaging in bilateral and multilateral 
partnerships to strengthen its national health system. For instance, the country 
has been an active participant of the Joint Learning Network on Universal 
Health Coverage (JLN), which seeks to co-develop “global knowledge 
products” that help implement complex health systems reforms to progress 
towards UHC (JLN, n.d.). Furthermore, the DoH is closely working with the 
Ministry of Public Health of Thailand on building capacity for health policy 
and systems research. Thai experts have trained Filipino practitioners on 
topics such as health technology assessment, while Philippine DoH staff have 
been seconded to Thailand’s International Health Policy Program (IHPP) and 
Health Intervention and Technology Assessment Program (HITAP) to gain 
experience in health policy research.
Finally, in addition to being a recipient of DAH, humanitarian aid and technical 
expertise, Philippines has become an emerging partner, leader and contributor 
in regional health cooperation within ASEAN. Over the past two decades, 
Philippines has collaborated with fellow ASEAN countries on joint initiatives to 
tackle diverse regional health issues such as pandemic preparedness, disaster 
management and NCDs. The Philippines has strongly advocated for crafting 
mutual recognition arrangements (MRAs) to facilitate international mobility of 
doctors, nurses and dentists as part of ASEAN regional economic integration, 
which started in 2015 (Invest in ASEAN, n.d.). In 2017, the Philippines served as 
the chair of ASEAN and led the 50th anniversary celebrations. The Philippines 
spearheaded the drafting of three health-focused, high-level declarations 
signed by the heads of State on ending malnutrition, enhancing disaster 
management and addressing AMR (ASEAN, 2017).
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1.3.4 Regional leadership: DAH, technical expertise and 
influencing global norms
In addition to traditional donors, the involvement of several countries 
within Asia, such as China, Japan, India and the Republic of Korea, has 
been an important aspect of regional cooperation for health, particularly 
in the context of decreasing assistance from Western donors as countries 
transition from low- to middle-income status (The Asia Foundation, 
2014). Japan (Box 1.3) has long been a major donor in Asia, although other 
countries are now providing increasing support to health programmes in 
the region, including LMICs such as Thailand through its International 
Cooperation Agency (TICA). Indeed, China has transitioned from being 
the world’s largest recipient of aid to a net provider of foreign assistance 
by 2011, and, while hotly contested, its “New Silk Road” or the so-called 
“Belt and Road Initiative” has promised to transform the landscape of 
DAH (Gostin, 2018). Moreover, the Government of Indonesia has recently 
announced that it will be establishing a single agency for its international 
aid programmes called Indonesian Aid with an initial budget of US$ 74 
million (Sheany, 2018). Development banks in Asia, namely the ADB 
and the New Development Bank (NDB), are becoming increasingly 
influential in the regional health architecture, particularly in funding 
health programming and generating coherence across health policy and 
other areas of public policy and their lending priorities. Much of the 
health programming in the region is also dependent on contributions from 
innovative global health initiatives, such as the Global Health Innovative 
Technology (GHIT) Fund and the Public Health Foundation of India (PHFI).
In addition to financial contributions, some Asian countries are also 
emerging as regional leaders through the provision of technical assistance, 
such as Thailand (Wenham, 2018), and the facilitation of regional health 
policy discussions, as demonstrated by the case of Philippines (Panel 2). 
More South–South collaboration around trade and health is important in 
Asia, given the context of a rising burden of NCDs that are driven in part 
by policy incoherence between trade policies and public health (Baker, Kay 
and Walls, 2015). For example, while most ASEAN member countries have 
embraced the WHO Framework Convention on Tobacco Control (FCTC) 
(except Indonesia) and have actively implemented some form of tobacco 
control policy, many States also invest in or promote the tobacco industry 
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where tobacco manufacturing is a State enterprise in some countries, 
often justifying such behaviour on the grounds of poverty alleviation and 
economic growth (Chongsuvivatwong et al., 2011).
Asian states are improving regional governance for health by both 
implementing and shaping regional and global health agendas and 
norms. For instance, many Asian states have been signatories to global 
health frameworks, including, for instance, the IHR (2005) and the FCTC. 
Implementation of tobacco control measures with the FCTC, however, has 
been mixed. For example, exposure to second-hand smoke is a common 
problem across Asia; in Pakistan, for instance, more than 80% of people are 
exposed to second-hand smoke in restaurants (Drope et al., 2018). Other 
countries such as Indonesia have yet to sign the FCTC despite 76.2% of men 
in the country smoking daily (The Tobacco Atlas, n.d.). By contrast, some 
countries are leading by example in implementing global commitments; 
Singapore has been one of the top performers in progressing towards the 
health-related SDGs, ranking in the highest quintile of countries across the 
globe (Lim et al., 2016).
In addition to implementing global health norms at the national level, Asian 
States are also increasingly shaping these norms and frameworks. During 
the FCTC negotiations, for example, the governments of India and Thailand 
strongly advocated for the participation of CSOs, which proved to be 
critical to the success of implementing the FCTC (Lee, Pang and Tan, 2013). 
ASEAN and the WHO Regional Office for South-East Asia also played 
important roles in the FCTC process by balancing various tobacco-related 
interests and generating consensus among discordant States at the regional 
level before engaging in global negotiations at the Conference of Parties 
(Lee, Pang and Tan, 2013). In terms of UHC, Japan (Box 1.3) and Thailand 
(Box 1.4) have been influential in advocating for national prioritization of 
UHC in the region and at the United Nations General Assembly (UNGA).
At the same time, however, it has been argued that Asian countries have 
largely been “rule takers” instead of “rule makers” in terms of global health 
frameworks and norms, largely due to their limited capacity to engage 
in global health negotiations in a proactive way and to enduring tensions 
between notions of sovereignty and collective action (Yeling, Lee and 
Pang, 2012).
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Box 1.3 Japan’s global health leadership
Japan has long prioritized global health in its approach to international 
diplomacy. For instance, action on health issues has been central to Japan’s 
agenda in all of the Group of Seven (G-7) Summits it has hosted (Sakamoto 
et al., 2018). At the Okinawa Summit in 2000, Japan’s leadership on infectious 
diseases was critical to the establishment of the Global Fund, to which the 
country continues to provide funding support. In 2016 alone, Japan pledged 
US$ 800 million for 2017–2019 to the Global Fund’s Fifth Replenishment, a 46% 
increase compared to its previous pledge, and the largest proportional increase 
among government donors (The Global Fund, 2017b).
Japan also hosted the G-8 Summit in Hokkaido in 2008 where it highlighted 
the importance of strong health systems. Importantly, Japan will host, for the 
first time, the G-20 Summit in Osaka in June 2019 where the country’s health 
priorities and strategies will be presented. The Summit will be followed by a 
Health Ministers’ Meeting in October 2019 in Okayama.
Japan’s leadership was also critical to the inclusion of UHC in the SDGs (Abe, 
2015), which Japan continued to promote throughout its G-7 presidency in 
2016 (Sakamoto et al., 2018). Drawing on its great progress towards UHC since 
the early 1960s during a time of rapid economic development, Japan continues 
to provide assistance to LMICs to work towards achieving resilient and 
sustainable health systems and reducing inequalities (Shiozaki, 2016).
The country has also led the global community on innovation in global 
health through, for example, the GHIT Fund, an international public–private 
partnership that funds research to address the burden of priority infectious 
diseases and poverty in LMICs (GHIT Fund, n.d.). Japan was also the 
fifth-largest global health donor among members of the Organization for 
Economic Co-operation and Development (OECD) Development Assistance 
Committee (DAC) in 2016 (Donor Tracker, n.d.).
Recently, Japan has not only identified but also led and contributed to global 
health as a key tenant of their long-term health-care policy vision, “Japan’s 
Vision: Health Care 2035”, which will guide the country’s health systems 
reforms over two decades (Miyata et al., 2015). Importantly, as the fastest 
ageing nation, addressing domestic health-care challenges associated with 
ageing societies will be critical for Japan and will also enable them to share 
lessons with other countries in the region regarding how health systems can be 
sustainable while ensuring equity (Shiozaki, 2016).
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Box 1.4 Thailand as a role model for regional health cooperation
Thailand is another key global health leader, particularly given its domestic 
progress towards UHC at a relatively low cost (Reich et al., 2016). Given that 
the country’s rapidly growing economy has attracted many migrants from 
neighbouring Asian countries, particularly from Cambodia and Myanmar, 
the country has also emerged as a leader in extending coverage to registered 
and non-registered migrants working in the formal sector (Suphanchaimat, 
Pudpong and Tangcharoensathien, 2017; Tangcharoensathien, Thwin and 
Patcharanarumol, 2017), although there have been challenges in extending 
coverage to those with a precarious immigration status (Guinto et al., 2015). 
Thailand chaired the long negotiation for a WHO Global Code of Practice on 
the International Recruitment of Health Personnel, the second WHO voluntary 
Code at the 2010 World Health Assembly and has been playing an active 
role in health workforce policies (Taylor and Dhillon, 2011). As Chair of the 
Foreign Policy and Global Health Group (a group of seven countries convened 
through the Oslo Ministerial Declaration, comprising Brazil, Indonesia, 
France, Norway, Senegal, South Africa and Thailand), in 2017, Thailand had 
tabled two UNGA resolutions related to UHC; inter alia, one calls for a UN 
high-level meeting on UHC in 2019 and the other proclaims 12 December as 
International UHC Day (Oslo Ministerial Declaration, 2007). Thailand has also 
led by example when it comes to generating coherence across trade and health 
policies (Thaiprayoon and Smith, 2015), sharing its experiences of health 
systems development, and providing humanitarian and technical assistance to 
neighbouring countries in Asia, as well as outside of the region in Africa and 
the Pacific Islands (Ministry of Public Health, 2017). 
As noted above, Thailand has played important roles in negotiating global 
frameworks such as the FCTC, as well as in challenging global intellectual 
property regulations to improve access to medicines (Moon and Szlezák, 2013). 
Global health cooperation will remain a top priority on the national agenda, 
as evidenced by the adoption of the Global Health Strategic Framework 
2016–2020, which seeks to strengthen Thailand’s leadership and role in 
agenda-setting at the regional and global levels (Ministry of Public Health, 
2017).
1.3.5 The contested space for civil society engagement
CSOs – referring to those organizations that operate outside of the State 
and the market (Lee, 2010) – play an important role in regional governance 
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for health. This group of actors is highly diverse (Youde, 2012). For 
example, in Bangladesh, CSOs range from large-scale organizations with 
multimillion-dollar budgets that employ thousands of people to local-level 
grass-roots organizations (Clayton, Oakley and Taylor, 2000). Despite 
this diversity, some common roles for this group include advocacy, 
policy-making, strengthening accountability, service provision, and 
bridging the gap between regional governance and local implementation 
(Nodzenski et al., 2016). The world’s largest NGO in this area, BRAC based 
in Bangladesh, has contributed substantially to health improvement in rural 
communities throughout Bangladesh and has become a critical component 
of the country’s health-care delivery system (Chowdhury et al., 2013). Other 
examples at the national level include networks and organizations of people 
living with HIV in Cambodia and Thailand, which have had a prominent 
role in response efforts and in ensuring that the rights of those affected 
by HIV/AIDS are promoted and protected (Wells-Dang and Wells-Dang, 
2011); indeed, civil society’s contribution was key to scaling up access to 
antiretroviral therapy to meet universal coverage in Thailand (Tantivess and 
Walt, 2008). At the regional level, Solidarity for Asian People’s Advocacy 
(SAPA) aims to enhance communication, cooperation and coordination 
among NGOs working in Asia, engaging key regional actors such as 
ASEAN (Nodzenski et al., 2016). At the local level, CSOs in Asia have been 
particularly effective in service delivery for vertical programmes, but have 
delivered fewer results in more horizontal programming, largely due to 
their reliance on external donors that favour disease-specific approaches 
(Wells-Dang and Wells-Dang, 2011). CSOs have also been particularly 
important health-care providers in Asia, sometimes working in partnership 
with governments (Zaidi et al., 2017). An example of this type of 
collaboration that has made a considerable impact is the Heartfile Lodhran 
cardiovascular disease (CVD) prevention project in Pakistan, which is 
jointly delivered by Heartfile – an NGO aimed at improving health systems 
to progress towards UHC in Pakistan and in other LMICs (Heartfile, n.d.) 
– and the National Rural Support Program in Lodhran district, which 
implemented a community-based CVD primary prevention project to 
train “lady health workers” as a means to reach populations that would 
otherwise be excluded (Nishtar et al., 2007).
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Despite some collaboration between governments and civil society in 
Asia, it has been argued that the influence of CSOs in governance in the 
region has been relatively limited, and that cooperation between national 
and regional bodies and civil society has not been institutionalized (Lamy 
and Phua, 2012a; Nodzenski, 2012; Nodzenski et al., 2016). By contrast, 
Asian governments could draw on the unique position of civil society to 
gain legitimacy and political support to influence both regional and global 
governance for health (Gostin, 2013).
1.3.6 The expansion of the private for-profit sector
Alongside CSOs, a wide range of privately owned for-profit institutions 
and individuals are playing an increasing role in the health architecture 
in Asia. Health services have become an important industry with a mix 
of formal and informal, private and public providers, together with a 
growth in medical tourism and international trade in health services 
(Chongsuvivatwong et al., 2011). The private for-profit sector has 
traditionally played multiple roles, which vary across countries and include 
service delivery in both the formal and informal sector, technical expertise 
and capacity-building, research and development activity, manufacturing 
and distribution of pharmaceutical products, developing new medical 
technologies, and financing global and regional activities. The private 
sector’s role in health-care delivery is heterogeneous in the region. In India, 
for example, the private sector dominates service provision, with a high 
private share of health expenditure and a low ratio of public spending to 
gross domestic product (GDP); whereas in Thailand, public sector spending 
supports a universalist public sector that is complemented by private sector 
investment and activities (Mackintosh et al., 2016). As these examples 
show, the private sector has engaged in service provision alongside the 
public sector in many countries, expanding health-care coverage; however, 
concerns have been raised that private for-profit providers divert doctors 
and nurses from the public health sector, exacerbating shortages in human 
resources. In addition, the for-profit private sector is often weakly regulated 
across Asia (Florini, 2014); regulation of the private sector should seek to 
ensure that service provision is fair and equitable, and aligned to national 
and regional strategies (Morgan, Ensor and Waters, 2016). Medical tourism 
is another area that the private sector has promoted in countries such as 
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Singapore and Thailand, capitalizing on their comparative advantage to 
sell health services and other recreational packages to “wealthy foreigners” 
(Chongsuvivatwong et al., 2011). Finally, the region is home to some 
of the most innovative forms of public–private mix in health services 
(Chongsuvivatwong et al., 2011) and there is growing recognition of the 
importance of public–private collaboration to achieve regional health 
goals, although there is a need for new mechanisms to harness the positive 
developments and to address the remaining challenges.
1.4 The complexity of the regional health architecture
As discussed in the preceding sections, the regional health architecture in 
Asia is characterized by its complexity. Citing Simon (1962, p. 468), Koenig-
Archibugi (2013) highlights that complex systems can generally be defined 
as those “made of a large number of parts that interact in a non-simple 
way”. As with global governance for health more broadly, complexity in the 
regional health architecture is related to the unstructured nature of health 
cooperation and the plurality of actors operating in this space (Koenig-
Archibugi, 2013). In Asia in particular, the diversity of political, cultural, 
religious, linguistic and economic arrangements across countries poses a 
significant barrier to generating collective action (Lamy and Phua, 2012; 
Lee, Pang and Tan, 2013). So too does the primacy of the non-interference 
principle in the region and the associated lack of willingness in some 
contexts to contribute to regional health collaboration, which in turn relies 
on the challenge of sustaining donor funding. Health services are uniquely 
complex in Asia as they have become a lucrative industry in the region 
with, for example, a growing market for medical technologies, medical 
tourism and trade in health services, alongside a mix of public and for-
profit providers that are often weakly regulated (Chongsuvivatwong et al., 
2011). This lack of regulation and unique landscape of health-care markets 
makes governing health in the region particularly complex. The regional 
architecture is therefore characterized by a low level of communication, 
data-sharing and best practices management between the various actors, 
and cooperation appears ad hoc rather than strategic (Nodzenski et al., 
2016). To add to this complexity, health programming in the region is 
highly decentralized, with multiple overlapping initiatives that are often 
underpinned by different normative frameworks, timeframes and objectives 
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(Liverani, Hanvoravongchai and Coker, 2013). Similarly, the institutional 
landscape in the region, as with the global health landscape more broadly, 
lacks the necessary coherence to address cross-sectoral health issues (Lee, 
Pang and Tan, 2013), as shown by the example of tobacco control.
1.5 Regional cooperation and communicable disease 
control in Asia
The case of communicable disease control in Asia further illustrates 
the complex dynamics of regional health governance. As previously 
discussed, the prevention and control of communicable diseases has been 
a key area for regional health cooperation in different Asian contexts. In 
South-East Asia, early initiatives were developed during the 2000s, in 
recognition of the transnational nature of endemic and emerging diseases 
and the need for collective action between neighbouring countries to 
address common health threats. For example, the Mekong Basin Disease 
Surveillance (MBDS) network, established in 2000, has been a pioneering 
and ambitious attempt to create a regional infrastructure for infectious 
disease control in South-East Asia, involving Cambodia, China (Yunnan 
province), Lao People’s Democratic Republic, Myanmar, Thailand and 
Viet Nam (Phommasack et al., 2013). Based on equal participation, rotating 
leadership and mutual learning, the MBDS network adopted a distinctive 
governance model in which each member country is responsible for the 
management and coordination of one specific programme component: 
cross-border cooperation (Lao People’s Democratic Republic), human–
animal sector interface and community-based surveillance (Viet Nam), 
human resources development (Thailand), ICT capacities (Cambodia), risk 
communication (Myanmar) and laboratory capacities (China). Further, 
MBDS has developed an extensive regional network for the cross-border 
sharing of expertise, epidemiological data and information, from the local 
communities to the provincial and central levels. Similarly, the Middle East 
Consortium on Infectious Disease Surveillance (MECIDS) was established 
in 2003 to facilitate public health cooperation between Israel, Jordan and 
Palestine – a prominent reminder that a concern with shared health issues 
can bridge political disputes and promote the pursuit of the common good 
(Leventhal et al., 2006).
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Over the past two decades, other regional programmes for the prevention 
and control of infectious diseases have been established in Asia, either 
focused on specific diseases such as HIV (Sharma and Chatterjee, 2012) and 
avian influenza (ADB, 2014) or “horizontal” in scope such as the MBDS and 
MECIDS networks. In addition, specific initiatives have been developed 
to support malaria control at the regional or subregional level, including 
the Asia Pacific Leaders Malaria Alliance (APLMA), an advocacy forum 
for high-level engagement and regional coordination, and the Strategy for 
Malaria Elimination in the Greater Mekong Subregion (GMS) (2015–2030). 
In the GMS, the identification of artemisinin resistance at the Cambodia–
Thailand border – and subsequent reports of widespread cross-border 
transmission (Ashley et al., 2014) – has also prompted the adoption of a 
regional emergency response (WHO, 2013). To deal with the resurgence 
of malaria in the region, especially threats posed by artemisinin-resistant 
strains in the Mekong Basin, the Australian DFAT and the Gates Foundation 
have established the APLMA with the objective of malaria elimination in 
the region by 2030 (APLMA Secretariat, n.d.).
Individual countries have also taken the lead in promoting regional 
information and data-sharing. Given the continuing problems with 
dengue in all countries of the region, Singapore has shown leadership in 
establishing the UNITEDengue initiative, which aims for timely and open 
sharing of epidemiological and virological surveillance data on dengue 
between countries in the region (UNITEDengue, n.d.).
As described earlier, organizations for political and economic cooperation 
have also provided institutional platforms to support regional public 
health programmes and strategies. To different degrees, the prevention and 
control of infectious diseases has been on the agenda of the ASEAN Plus 
Three, the ADB, SAARC and APEC, in joint action with the WHO Regional 
Office for South-East Asia and the WHO Regional Office for the Western 
Pacific. For example, as part of the ASEAN work programme in the health 
sector (2016–2020), the ASEAN Secretariat coordinates a wide range of 
activities for the prevention and control of infectious diseases, including 
continued support to existing disease surveillance networks, preparedness 
through joint simulation exercises and the establishment of regional 
mechanisms to supply less-resourced countries with drugs/vaccines in 
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the event of outbreaks, and the ASEAN Field Epidemiology Training 
Programme (FETP), led by Thailand (ASEAN, n.d.-b).
This diverse range of initiatives has contributed to intensification in various 
forms of collaboration between Asian countries, including the exchange of 
epidemiological data and information between regional partners for routine 
disease surveillance or in the event of emergencies. Additionally, the 
increase in regional meetings, the close collaboration through cross-border 
health committees and workshops has promoted the sharing of expertise, 
experiences and good practices among health professionals, policy-makers 
and other stakeholders. Gradually, these collaborations build and sustain 
trust among local front-line public health workers and local policy-makers, 
which foster close collaboration.
Despite these achievements, key challenges remain. Regional public health 
cooperation and information-sharing is crucial to infectious disease control, 
particularly in transnational disease “hotspots”, such as the GMS, where 
cross-border population mobility, the regional ecosystem and trade may 
facilitate disease emergence and transmission. However, the achievement 
of effective regional cooperation requires convergence and communication 
between different public health systems (including systems for the 
collection and dissemination of epidemiological data), which are variably 
shaped by national governance structures, capacities, rules and practices 
(Liverani et al., 2018).
The nature of institutional and legal arrangements in place is another 
important variable that may affect the practice of international cooperation. 
Asian countries are bound to the provisions in the IHR (2005), which 
require health authorities to report to WHO and Member States health 
threats of international concern within 24 hours of detection. However, 
national capacities to implement the IHR are variable and, consequently, 
so are their abilities to report disease outbreaks to neighbouring countries 
and global health organizations. In addition, virtually all regional health 
programmes in Asia have been established through non-binding “soft law” 
agreements such as memoranda of understanding; thus, they provide weak 
legal bases to support collective action, especially for complex interventions 
that require clear rules and operating procedures, such as joint outbreak 
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investigations. Regional organizations such as ASEAN and SAARC 
have the potential to support regulatory convergence, common rules 
and standards in collaboration with WHO, given their well-established 
institutional profile. However, as noted earlier, these organizations have 
historically been influenced by consensus in decision-making and a strong 
sensitivity towards national sovereignty, limiting their power to develop 
and enforce provisions in sensitive areas such as regional (health) security 
(Liverani, Hanvoravongchai and Coker, 2012; Pattanaik, 2010). Lastly, the 
implementation of regional programmes for infectious disease control in 
both South and South-East Asia has benefited from the financial assistance 
of donor countries, private philanthropists such as the Rockefeller 
Foundation, the Global Fund and development finance institutions 
such as the ADB (Coker et al., 2011). This large flow of donor funds has 
undoubtedly contributed to building an infrastructure for regional public 
health cooperation. Yet, funding is usually provided to support stand-alone 
programmes, raising concerns about the integration of these programmes in 
the wider national health systems and their sustainability in the long term.
1.6 Conclusions
This chapter provides an overview of the regional health architecture 
in Asia and its governance, with examples from different contexts. It 
has shown that the health architecture in Asia is characterized by its 
complexity. While a sense of solidarity and a shared vulnerability to health 
threats has encouraged collective action in the region, regional governance 
for health remains a complex and demanding task, requiring convergence 
and communication between different health systems, as well as diverse 
political, economic, social and cultural arrangements. The unique nature 
of health services, which have become a lucrative industry in the region – 
particularly in the context of an expanding market for medical technologies, 
medical tourism and trade in health services – alongside the mix of 
public and private providers present distinct challenges for governance 
(Chongsuvivatwong et al., 2011). Case studies from Cambodia and the 
Philippines illustrate how insufficient coordination between donors and 
their sponsored programmes throughout Asia has resulted in a lack of 
synergies across health initiatives, as well as the prioritization of vertical 
disease programmes that may not necessarily reflect national health needs. 
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However, the examples also show how Asian states are developing new 
mechanisms to promote coherence across programmes at the national and 
regional levels.
To overcome some of these barriers and improve health cooperation in 
Asia, regional organizations such as ASEAN and SAARC are in a good 
position to promote regulatory convergence, common rules and standards, 
given their well-established institutional profiles but not without their own 
challenges. Increased investment will be important to facilitate greater 
cooperation between states and to improve coherence across sectors.
Lastly, amid shifting political and economic influence from the West to 
the East, a so-called “Rising Asia” presents an important opportunity to 
strengthen regional cooperation and improve global health capacities to 
contribute more firmly as a region to global governance for health (Yeling, 
Lee and  Pang 2012). Case studies from Thailand and Japan show that 
regional actors are gaining prominence in this space and are increasingly 
committed to taking the lead on coordination roles and on global health 
agenda-setting. One key area of opportunity would be for Asian actors 
to capitalize on growing political and economic power to lead more 
South–South collaborations and gradually become “rule-makers and 
game-setters”. Looking ahead, given the rise in relevance of global health 
in Asia, and the associated expansion of the regional health architecture, 
actors throughout the region have a critical opportunity to generate greater 
dialogue, synergies and commitment to regional governance for health and 
to lead more firmly in the global health space.
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